GUTS

FRACTYL HEALTH, INC.

Healthcare · Biotechnology

$317.08 sample

-5.24 (-1.63%) 1D

Market cap

$884.9B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$317.08 +13.43% 3M daily closessample

325.59276.47

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Chief Financial Officer
Oct 07INSInsider sell: 10% owner
Sep 30INSInsider buy: Chief Financial Officer
Sep 23INSInsider buy: EVP, Operations
Sep 15INSInsider buy: General Counsel
Sep 08INSInsider sell: General Counsel
Aug 28INSInsider sell: Director
Aug 21INSInsider sell: EVP, Operations

Sign up to see the real GUTS record →

Company facts

SEC EDGAR registration

Name: FRACTYL HEALTH, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -4sample, -100 to +100
Reporting currency: USD

Who is positioning in GUTS

sample

Insiders: 25 insider transactions over 90 days, net selling, $102.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 31 funds hold $11.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$52.7B +12.1% y/y

Q4 2024Q3 2026

Inventory$31.3B +9.3% y/y

Q4 2024Q3 2026

Accounts receivable$24.4B +12.6% y/y

Q4 2024Q3 2026

Total debt$63.6B +15.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $473.1B +8.0% 3M
Sample peer B: $285.1B +14.8% 3M
Sample peer C: $134.1B +2.2% 3M
Sample peer D: $619.2B -4.0% 3M
Sample peer E: $204.8B +3.9% 3M